A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 4, 2011, Pages 455-460

  Peridis, Stamatios ^a   Pilgrim, Gemma ^a   Athanasopoulos, Ioannis ^b   Parpounas, Konstantinos ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Airway; Haemangioma; Infantile; Paediatric; Propranolol

Indexed keywords

PROPRANOLOL; STEROID; VINCRISTINE;

BRONCHOSPASM; CARBON DIOXIDE LASER; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEMANGIOMA; HUMAN; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; MALE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SEX RATIO; TREATMENT OUTCOME; TUMOR LOCALIZATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; LARYNGEAL NEOPLASMS; LASER THERAPY, LOW-LEVEL; MALE; PROGNOSIS; PROPRANOLOL; RISK ASSESSMENT; STEROIDS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 79952736210     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.01.028     Document Type: Review

References (31)

1. Chang L.C., Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S.L., Garzon M.C., et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008, 122:360-367.
2. Zimmermann A.P., Wiegand S., Werner J.A., Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:338-342.
3. Perkins J.A., Duke W., Chen E., Manning S. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol. Head Neck Surg. 2009, 141:207-212.
4. Perkins J.A., Oliaei S., Garrison M.M., Manning S.C., Christakis D.A. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:1302-1307.
5. Buckmiller L.M. Propranolol treatment for infantile hemangiomas. Curr. Opin. Otolaryngol. Head Neck Surg. 2009, 17:458-459.
6. Buckmiller L.M., Munson P.D., Dyamenahalli U., Dai Y., Richter G.T. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010, 120:676-681.
7. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., Boralevi F., Thambo J.B., Taïeb A. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008, 358:2649-2651.
8. Denoyelle F., Garabédian E.N. Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Otolaryngol. Head Neck Surg. 2010, 142:463-464.
9. Clarke M., Horton R. Bringing it all together: lancet-cochrane collaborate on systematic reviews. Lancet 2001, 357:1728.
10. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
11. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7:177-188.
12. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
13. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
14. G.A. Wells, B. Shea, D. O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.(accessed: Jan 15, 2011). http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
15. Athanasiou T., Al-Ruzzeh S., Kumar P., Crossman M.C., Amrani M., Pepper J.R., et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann. Thorac. Surg. 2004, 77:745-753.
16. Taggart D.P., D' Amico R., Altman D.G. Effect of arterial revascularization on survival: a systemic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001, 358:870-875.
17. Mistry N., Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J. Laryngol. Otol. 2010, 124:1329-1332.
18. Buckmiller L., Dyamenahalli U., Richter G.T. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009, 119:2051-2054.
19. Maturo S., Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:323-325.
20. Truong M.T., Perkins J.A., Messner A.H., Chang K.W. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:1043-1048.
21. Rosbe K.W., Suh K.Y., Meyer A.K., Maguiness S.M., Frieden I.J. Propranolol in the management of airway infantile hemangiomas. Arch. Otolaryngol. Head Neck Surg. 2010, 136:658-665.
22. Truong M.T., Chang K.W., Berk D.R., Heerema-McKenney A., Bruckner A.L. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J. Pediatr. 2010, 156:335-338.
23. Denoyelle F., Leboulanger N., Enjolras O., Harris R., Roger G., Garabedian E.N. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:1168-1172.
24. Blanchet C., Nichollas R., Bigorre M., Amedro P., Mondain M. Management of infantile subglottic hemangioma: acebutolol or propranolol?. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:959-961.
25. Theletsane T., Redfern A., Raynham O., Harris T., Prose N.S., Khumalo N.P. Life-threatening infantile haemangioma: a dramatic response to propranolol. J. Eur. Acad. Dermatol. Venereol. 2009, 23:1445-1469.
26. Manunza F., Syed S., Laguda B., Linward J., Kennedy H., Gholam K., et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br. J. Dermatol. 2010, 162:452-468.
27. Leboulanger N., Fayoux P., Teissier N., Cox A., Van Den Abbeele T., Carrabin L., et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:1254-1257.
28. Sans V., de la Roque E.D., Berge J., Grenier N., Boralevi F., Mazereeuw-Hautier J., et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009, 124:423-431.
29. Jephson C.G., Manunza F., Syed S., Mills N.A., Harper J., Hartley B.E. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:1821-1823.
30. Saetti R., Silvestrini M., Cutrone C., Narne S. Treatment of congenital subglottic hemangiomas. Arch. Otolaryngol. Head Neck Surg. 2008, 134:848-851.
31. Siegfried E.C., Keenan W.J., Al-Jureidini S. More on propranolol for hemangiomas of infancy. N. Engl. J. Med. 2008, 359:2846-2847.